2
↑0
↓0
—2
Evidence suggests Creatine haslittle to no effecton Safety.
2 studies (2 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
2 of 2
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| creatine | No effect - no safety concerns | safety | Human | Six participants with ALS | 5, 10, and 15 g twice daily (b.i.d.). | A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis.cited 28× |
| creatine | No effect - considered safe and without significant adverse effects | safety | Human | — | Variable, with multiple regimens showing benefits (specific amounts not detailed). | Creatine Use in Sports.cited 47× |